Document ID: chunk:federal_register_of_legislation:F2018L00556:front:0:p2
Version: federal_register_of_legislation:F2018L00556
Segment Type: other
Provision Reference: 
Character Range: 2891–5863

of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
     Death from Cushing syndrome
(5)          For the purposes of this Statement of Principles, Cushing syndrome, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's Cushing syndrome.
Note: terminal event is defined in the Schedule 1 – Dictionary.
     8               Basis for determining the factors
On the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that Cushing syndrome and death from Cushing syndrome can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
     9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, Cushing syndrome or death from Cushing syndrome is connected with the circumstances of a person's relevant service:
(1)          having a specified condition at the time of the clinical onset of Cushing syndrome;
Note: specified condition is defined in the Schedule 1 - Dictionary.
(2)          having glucocorticoid therapy as specified before the clinical onset of Cushing syndrome, and where the glucocorticoid therapy as specified has ceased or decreased, the last dose of the therapy was received within the 30 days before the clinical onset of Cushing syndrome;
Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(3)          being treated with medroxyprogesterone acetate or megestrol acetate for a malignant disease or human immunodeficiency virus infection:
(a)          for at least four weeks before the clinical onset of Cushing syndrome; and
(b)          where treatment has ceased, the clinical onset of Cushing syndrome has occurred within 30 days of cessation;
(4)          inability to obtain appropriate clinical management for Cushing syndrome.
     10           Relationship to service
     (1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
     (2)          The factor set out in subsection 9(4) applies only to material contribution to, or aggravation of, Cushing syndrome where the person's Cushing syndrome was suffered or contracted before or during (but did not arise out of) the person's relevant service.
     11           Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1)          if a factor referred to in section 9 applies in relation to a person; and
(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;
then the factors